• Michael Levy

    Michael has served on the Board of Directors and as Treasurer of MassBioEd since June 2019. Separately, he is the Senior Director of Accounting at Relay Therapeutics, a clinical stage precision medicines company focused on protein motion, which is used to facilitate the selection and advancement of unique product candidates into novel therapies. Before joining Relay Therapeutics, he worked as the Corporate Controller at Triplet Therapeutics and as an Assurance Senior Manager in Ernst & Young LLP’s Life Sciences Practice in Cambridge, MA  for over 11 years. In connection therewith, he assisted clients in the life sciences industry with various accounting and auditing matters. Finally, he received his Bachelor of Science in Business Administration from Boston University and is a member of the American Institute of Certified Public Accountants, as well as the Massachusetts Society of Certified Public Accountants.

    Learn More
  • Stacie Sawchak Aarestad

    Stacie is a partner in Foley Hoag’s Securities Practice Group and M&A Practice Group. She focuses her practice on corporate and securities law matters, public company representation and merger and acquisition transactions. She represents issuers in a broad range of capital market transactions, including public and private offerings of debt and equity securities and also advises companies with respect to tender offers, exchange offers, debt repurchases and stock buybacks. Stacie received her B.A. magna cum laude from Colgate University in 1991 and her J.D. magna cum laude from Boston University School of Law in 1997.

    Learn More
  • Lauren Celano

    Lauren is the co-founder and CEO of Propel Careers, a life science search and career development firm focused on connecting talented individuals with entrepreneurial life sciences companies.  Propel works with current leaders and actively cultivates future leaders through full time placement, internships, mentoring, career coaching, and networking.  Propel Careers is engaged  across all areas of life sciences, including therapeutics, medical devices, healthcare IT, diagnostics, consulting, venture capital, and investment banking. Prior to Propel Careers, Lauren was a senior account manager for SNBL USA where she worked with emerging biotech companies in Europe, Asia, and the US to help characterize and advance their drug molecules. Prior to SNBL USA, she held business development positions with Aptuit and Quintiles, where she focused on IND enabling studies to advance therapeutics from discovery into the clinic.  Earlier in her career, Lauren held positions as a marketing manager and account manager at Absorption Systems, where she was responsible for managing life sciences companies in the northeastern United States.  She has a B.S. in Biochemistry and Molecular Biology from Gettysburg College and an MBA with a focus in the health sector and entrepreneurship from Boston University. Lauren is the Vice-Chair on the Board of MassBioEd and the Advisory Boards of the Boston University School of Public Health Pharmaceuticals Program, the Professional Science Masters Program at Framingham State University and NE GWISE. She also serves on the selection committee for the Life Sciences Immigrant Entrepreneur of the Year Award since 2014 with the Immigrant Learning Center.

    Learn More
  • Christopher Murphy

    Christopher has been a board member at MassBioEd since 2014 and is Vice President and General Manager of Viral Vector Services in Thermo Fisher Scientific’s Pharma Services Group.  He transitioned into this role when Thermo Fisher acquired Brammer Bio, where he served as chief operating officer. Christopher has more than 30 years of experience in biopharmaceutical manufacturing, process development, plant operations, and quality system implementation.  Prior to joining Brammer Bio, he served as general manager for the Sanofi-Genzyme Allston Landing site overseeing operations and leading an integrated remediation program associated with the consent decree. Christopher has led gene therapy operations and recombinant protein manufacturing at Genzyme and Bioreliance and he began his career in viral vaccine development at American Cyanamid/Wyeth (now Pfizer) in Pearl River, NY. He has a M.S. in biochemistry at New York Medical College, and his B.S. in biology at Rutgers University.

    Learn More